Servier Drug Catapults XOMA to Commercial Ops
By Marie Powers
Thursday, January 19, 2012
XOMA Corp. used the approved hypertension drug perindopril as a slingshot to hit its long-sought target of launching commercial operations in the U.S.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.